Ribotargets Receives Exclusive Ribosome License

RiboTargets has received an exclusive worldwide license to patents filed by the Medical Research Council (MRC) relating to the 30S subunit of the bacterial ribosome (30S). Pioneering research led by the MRC’s Dr Venki Ramakrishnan has elucidated the molecular structure of the 30S bacterial ribosome and the molecular interactions that enable ribosomes to assemble proteins Read more about Ribotargets Receives Exclusive Ribosome License[…]

RiboTargets And Sun Microsystems Collaborate

RiboTargets and Sun Microsystems Inc. have entered into a collaboration using high-powered computing methods to discover a novel class of antibiotic. In the collaboration, Sun committed a 200 processor SUN TCF (Technical Compute Farm) on which RiboTargets has been running its unique virtual screening software RiboDock. The software is designed to screen huge numbers of Read more about RiboTargets And Sun Microsystems Collaborate[…]